How antibodies block HIV infection: paths to an AIDS vaccine
- 31 May 1992
- journal article
- review article
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 17 (5) , 191-196
- https://doi.org/10.1016/0968-0004(92)90265-b
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Inhibition of Entry of HIV-1 in Neural Cell Lines by Antibodies Against Galactosyl CeramideScience, 1991
- Conserved Sequence and Structural Elements in the HIV-1 Principal Neutralizing DeterminantScience, 1990
- Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cellsNature, 1989
- HIV infection does not require endocytosis of its receptor, CD4Cell, 1988
- Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virusCell, 1988
- Functional Regions of the Envelope Glycoprotein of Human Immunodeficiency Virus Type 1Science, 1987
- Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptorCell, 1987
- Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virusCell, 1987
- pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membraneCell, 1987
- The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brainCell, 1986